CareDx, Inc. (CDNA)
Nasdaq · Common stock · Services-Medical Laboratories
As of Oct 30, 2:17 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow CDNA in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on CDNA and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
CDNA at a glance
Key statistics
$3.70B
Market capitalization
- Previous close
- $71.52
- Open
- $81.98
- Day range
- $81.98 – $90.43
- Volume
- 2.44M
- Average volume (30 sessions)
- 1.43M
- Shares outstanding
- 51.73M
- Price / earnings
- 28.8
- Earnings per share
- $2.49
- Price / book
- 7.9
- Price / sales
- 7.4
- Beta (1 year, vs SPY)
- 1.43
Where the price sits in its year
52-week range
94% of the range
- Below the 52-week high
- -5.2%
- Above the 52-week low
- +502.5%
Completed sessions through Oct 29, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $67.11+6.6%
- 50-day average
- $59.12+21.0%
- 200-day average
- $33.31+114.7%
Between the conventional 30 and 70 bands.
+3.4%
1 week
+10.0%
1 month
+63.6%
3 months
+279.6%
Year to date
+387.5%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with CDNA
CDNA on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on CDNA.
See the plans →
Every planScreen names like CDNA
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on CDNA
Put CDNA on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on CDNA
See whether there is an open premium alert on CDNA, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
CDNA headlines
- CareDx Sharpens Focus On Core Testing Services
Benzinga · Apr 16, 2026
- Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
GlobeNewswire Inc. · May 21, 2025
- ALERTA PARA LOS ACCIONISTAS: Morris Kandinov investiga a CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., y Tax Free Fund for Puerto Rico Residents, Inc.; se anima a los accionistas a ponerse en contacto con la firma
GlobeNewswire Inc. · Sep 24, 2024
- Where CareDx Stands With Analysts - Benzinga
Benzinga · Jul 17, 2024
- Decoding 6 Analyst Evaluations For CareDx
Benzinga · May 31, 2024
- Navigating 5 Analyst Ratings For CareDx
Benzinga · May 13, 2024
- Analyst Expectations for CareDx's Future
Benzinga · Mar 3, 2023
SEC Form 4, most recent first
Insider filings
Meng Jessica
−2.6K
Chief Commercial Officer · Shares withheld for tax
$173.46K · Oct 1, 2026
Kennedy Keith
−3.0K
CFO & COO · Shares withheld for tax
$199.88K · Oct 1, 2026
Novack Jeffrey Adam
−997
Secretary and General Counsel · Shares withheld for tax
$66.03K · Oct 1, 2026
Hanna John Walter JR
−8.5K
President and CEO, Director · Shares withheld for tax
$563.68K · Oct 1, 2026
Goldberg Michael
+588
Director · Grant or award
· Oct 2, 2026
Meng Jessica
−6.7K
Chief Commercial Officer · Shares withheld for tax
$350.25K · Sep 12, 2026
Kennedy Keith
−8.2K
CFO & COO · Shares withheld for tax
$430.48K · Sep 12, 2026
Goldberg Michael
−44.7K
Director · Open-market sale
$2.10M · Aug 4, 2026
About CareDx, Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Services-Medical Laboratories
- Headquarters
- Brisbane, CA
- Employees
- 765
- Listed since
- Jul 17, 2014
- Website
- caredx.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.